HK1089962A1 - 7-carboxymethyloxy-3', 4', 5-trimethoxy flavone monohydrate, the preparation method and uses thereof - Google Patents

7-carboxymethyloxy-3', 4', 5-trimethoxy flavone monohydrate, the preparation method and uses thereof

Info

Publication number
HK1089962A1
HK1089962A1 HK06110706.8A HK06110706A HK1089962A1 HK 1089962 A1 HK1089962 A1 HK 1089962A1 HK 06110706 A HK06110706 A HK 06110706A HK 1089962 A1 HK1089962 A1 HK 1089962A1
Authority
HK
Hong Kong
Prior art keywords
carboxymethyloxy
preparation
trimethoxy flavone
hydroxy
flavone monohydrate
Prior art date
Application number
HK06110706.8A
Other languages
English (en)
Original Assignee
Dong A Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong A Pharm Co Ltd filed Critical Dong A Pharm Co Ltd
Publication of HK1089962A1 publication Critical patent/HK1089962A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
HK06110706.8A 2003-09-04 2006-09-26 7-carboxymethyloxy-3', 4', 5-trimethoxy flavone monohydrate, the preparation method and uses thereof HK1089962A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020030061938A KR20050024121A (ko) 2003-09-04 2003-09-04 7-카르복시메틸옥시-3',4',5-트리메톡시 플라본.일수화물, 이의 제조방법 및 용도
PCT/KR2004/002247 WO2005023244A1 (en) 2003-09-04 2004-09-04 7-carboxymethyloxy-3', 4', 5-trimethoxy flavone monohydrate, the preparation method and uses thereof

Publications (1)

Publication Number Publication Date
HK1089962A1 true HK1089962A1 (en) 2006-12-15

Family

ID=36087516

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06110706.8A HK1089962A1 (en) 2003-09-04 2006-09-26 7-carboxymethyloxy-3', 4', 5-trimethoxy flavone monohydrate, the preparation method and uses thereof

Country Status (20)

Country Link
US (1) US7371775B2 (zh)
EP (2) EP1660074B1 (zh)
JP (2) JP2007504217A (zh)
KR (2) KR20050024121A (zh)
CN (2) CN100591332C (zh)
AT (1) ATE451918T1 (zh)
AU (1) AU2004270065B2 (zh)
BR (1) BRPI0413163A (zh)
CA (1) CA2533301C (zh)
DE (1) DE602004024687D1 (zh)
DK (1) DK1660074T3 (zh)
ES (1) ES2336000T3 (zh)
HK (1) HK1089962A1 (zh)
MX (1) MXPA06002383A (zh)
NZ (2) NZ544761A (zh)
PT (1) PT1660074E (zh)
RU (1) RU2302416C2 (zh)
SG (1) SG136960A1 (zh)
TR (2) TR200600987T1 (zh)
WO (1) WO2005023244A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100930467B1 (ko) 2007-06-07 2009-12-08 동아제약주식회사 점액분비를 촉진시키는 3',4',5-트리메톡시 플라본 유도체화합물, 그의 제조방법 및 약학적 용도
KR101381999B1 (ko) * 2007-07-06 2014-04-14 동아에스티 주식회사 위염 치료제의 효력을 극대화시키기 위한 가용화 위체류시스템 매트릭스 제제
KR20110010753A (ko) * 2008-05-08 2011-02-07 유나이티드 세러퓨틱스 코오포레이션 트레프로스티닐 일수화물
JP7121986B2 (ja) * 2018-08-16 2022-08-19 株式会社常磐植物化学研究所 アルコキシフラボン誘導体の製造方法
CN117794515A (zh) 2021-08-05 2024-03-29 格里医药科技公司 用于治疗干眼综合征的包含瑞可黄酮的滴眼剂组合物及其制备方法
WO2023014117A1 (ko) 2021-08-05 2023-02-09 지엘팜텍주식회사 안구건조증 치료를 위한 레코플라본 함유 점안 조성물 및 이의 제조방법
KR102356603B1 (ko) 2021-08-05 2022-02-08 지엘팜텍주식회사 안구건조증 치료를 위한 레코플라본 함유 점안 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623808B1 (fr) * 1987-12-01 1990-03-09 Adir Nouveaux derives flavonoides (benzyl-4 piperazinyl-1)-2 oxo-2 ethylene substitues, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
IT1245371B (it) * 1991-03-28 1994-09-20 Geymonat Spa Derivati di flavoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US5399584A (en) * 1992-05-05 1995-03-21 The Procter & Gamble Company Use of flavone derivatives for gastroprotection
US5525072A (en) 1995-01-10 1996-06-11 Molex Incorporated Electrical connector assembly for interconnecting a flat cable to a circuit board
KR100447918B1 (ko) * 1996-07-25 2005-09-28 동아제약주식회사 대장을포함한위장관보호작용을갖는플라본및플라바논화합물
KR19990041205A (ko) 1997-11-21 1999-06-15 이종수 전자 브레이크장치
KR100327621B1 (ko) * 1999-09-22 2002-03-15 유충식 7-카르복시메틸옥시-3',4',5-트리메톡시플라본의 제조방법

Also Published As

Publication number Publication date
CN101684113A (zh) 2010-03-31
NZ575796A (en) 2010-05-28
EP1660074A4 (en) 2008-02-27
SG136960A1 (en) 2007-11-29
EP1660074B1 (en) 2009-12-16
EP2065375A1 (en) 2009-06-03
JP2010138193A (ja) 2010-06-24
AU2004270065B2 (en) 2007-07-26
DE602004024687D1 (de) 2010-01-28
RU2006102956A (ru) 2006-06-10
EP1660074A1 (en) 2006-05-31
WO2005023244A1 (en) 2005-03-17
RU2302416C2 (ru) 2007-07-10
TR200603833T2 (tr) 2006-11-21
KR20050108369A (ko) 2005-11-16
DK1660074T3 (da) 2010-03-08
ES2336000T3 (es) 2010-04-07
CN1822829A (zh) 2006-08-23
NZ544761A (en) 2009-10-30
BRPI0413163A (pt) 2006-10-03
US20060178428A1 (en) 2006-08-10
MXPA06002383A (es) 2006-06-20
US7371775B2 (en) 2008-05-13
CN100591332C (zh) 2010-02-24
CA2533301A1 (en) 2005-03-17
ATE451918T1 (de) 2010-01-15
PT1660074E (pt) 2009-12-31
TR200600987T1 (tr) 2007-01-22
CA2533301C (en) 2011-01-04
CN101684113B (zh) 2012-05-23
KR100644928B1 (ko) 2006-11-15
AU2004270065A1 (en) 2005-03-17
JP2007504217A (ja) 2007-03-01
KR20050024121A (ko) 2005-03-10

Similar Documents

Publication Publication Date Title
HK1089962A1 (en) 7-carboxymethyloxy-3', 4', 5-trimethoxy flavone monohydrate, the preparation method and uses thereof
BR9704589A (pt) Extrato de proteína vegetal e material protéico enriquecidos com aglicona isoflavona material de alto teor de genisteína e daidzeína e processo parasua produção
IL162200A0 (en) Oxy-estratrienes-alkyl-17 17 and intermediates forthe production thereof, and use -oxy-alkyl-17 of said 17 estratrienes for producing
ATE288758T1 (de) Verfahren zur herstellung von polymorphen des clarithromycins
NZ594077A (en) Process for production of delta-9-tetrahydrocannabinol
WO2006058092A3 (en) Monosaccharide production system
HUP0103295A3 (en) Process for producing citalopram
WO2008040528A3 (en) Process for preparing nebivolol
BR0114437A (pt) Derivados de acido propiÈnico
FR2827277B1 (fr) Procede de preparation de carbures refractaires
DZ3111A1 (fr) Procédé de production des oléfines inferieures.
MXPA03009806A (es) Derivados de piperazino y su uso como inhibidor de fosfodiesterasa de nucleotido ciclico de tipo 4 (pde4).
WO2003072790A3 (en) Production of dadzein in transgenic plants
AU2001223714A1 (en) Method for producing n-methyl-n'-nitroguanidine
IL152295A0 (en) Method for producing 2-alkyl-3-chlorophenols
WO2007029266A3 (en) A process for preparing 9-deoxo-9a-aza-9a-homoerythromycin a
ITMI20000204A0 (it) Procedimento per la produzione di pannelli anti-crash impianto per lasua attuazione nonche' pannello ottenuto
AU2001289822A1 (en) Method for producing dihydrocoumarin by hydrogenating coumarin
AU2003211758A1 (en) Process for producing chromone compound
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
DK1417324T3 (da) Fremgangsmåde til fremstilling af 2-keto-L-gulonsyre
MXPA03002694A (es) Compuestos de 5-fenilbencilamina, procedimiento para su produccion e intermediarios para su sintesis.
AU1517601A (en) Method for production of benzofuranone oximes
MXPA04001846A (es) Indan-1-onas c2-substituidas y sus derivados, metodos para su produccion y su uso como medicamentos.
MXPA04001851A (es) Inda-1-onas c2-disustituidas y sus derivados, metodo para su produccion y su uso como medicamentos.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150904